Diagnostic Imaging's Weekly Scan: December 18-December 24
Check out the top radiology content of the past week.
Diagnostic Imaging's Weekly Scan is your chance to catch up on the latest radiology content, from new research and device news to the latest case quizzes and conference reports. Review the slideshow below to see this week's top content:
Click the arrows above to view top radiology content from the past week.
Study Shows Merits of Photon-Counting CT in Detecting Subtle Post-COVID Lung Abnormalities
In a recently published prospective study comparing photon-counting detector computed tomography (PCD CT) versus energy-integrating detector CT (EID CT) in patients with persistent symptoms after COVID-19 infection, researchers found that PCD CT discovered additional lung abnormalities in half of the study participants. READ MORE
DeepHealth Gets FDA Nod for AI Mammography Software That Assesses Breast Density
The artificial intelligence (AI) software Saige-Density™ reportedly provides automated assessment of breast density during mammography exams. READ MORE
Recognizing and Addressing Biases with AI and Radiologists
In a video interview discussing one of her recent leectures at the Radiological Society of North ASmerica (RSNA) conference, Nina Kottler, M.D., M.S., noted how the combination of artificial intelligence (AI) and radiologist experience can help mitigate bias limitations with the development of AI algorithms as well as educational biases inherent to a radiologist's training and experience. WATCH NOW
Can the Keto Diet Affect PET Imaging of the Brain?
Emerging research suggests that a ketogenic diet reduces the uptake of 18F-fluorodeoxyglucose (18F-FDG) in brain positron emission tomography (PET) scans with a more pronounced effects in the precuneus. READ MORE
Cytalux Gets Expanded FDA Approval for Intraoperative Imaging of Lung Cancer
Reportedly the first targeted molecular imaging agent to provide intraoperative illumination of lung cancer, Cytalux (pafolacianine) helped identify clinically significant events in more than 50 percent of patients undergoing surgery for confirmed or suspected pulmonary nodules, according to Phase 3 trial data prresented earlier this year at the American Association for Thoracic Surgery Annual Meeting. READ MORE
